Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-033517
Filing Date
2013-06-07
Accepted
2013-06-07 14:33:21
Documents
1
Period of Report
2013-06-05

Document Format Files

Seq Description Document Type Size
1 rrd381885.html 4  
1 rrd381885.xml 4 7642
  Complete submission text file 0001181431-13-033517.txt   8959
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
Weller Harry R (Reporting) CIK: 0001362942 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 13900270

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations